Dow Up 0.07% Nasdaq Up 0.61%

Agenus Inc. (AGEN)

-NasdaqCM
3.00 Up 0.04(1.35%) Nov 26, 4:00PM EST
Prev Close:2.96
Open:2.95
Bid:N/A
Ask:4.75 x 200
1y Target Est:6.50
Beta:2.65
Next Earnings Date:N/A
Day's Range:2.95 - 3.01
52wk Range:2.27 - 5.27
Volume:304,653
Avg Vol (3m):327,354
Market Cap:188.05M
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENUp 1.35%188.05M
ABPIUp 22.73%484.68K
DNDN 0.00%19.69M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.44
Quarterly EPS Est (Dec-14) :-0.16
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback